These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8228366)

  • 1. Efficacy of azithromycin for treating Babesia microti infection in the hamster model.
    Weiss LM; Wittner M; Wasserman S; Oz HS; Retsema J; Tanowitz HB
    J Infect Dis; 1993 Nov; 168(5):1289-92. PubMed ID: 8228366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atovaquone in the treatment of Babesia microti infections in hamsters.
    Wittner M; Lederman J; Tanowitz HB; Rosenbaum GS; Weiss LM
    Am J Trop Med Hyg; 1996 Aug; 55(2):219-22. PubMed ID: 8780464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone and azithromycin for the treatment of babesiosis.
    Krause PJ; Lepore T; Sikand VK; Gadbaw J; Burke G; Telford SR; Brassard P; Pearl D; Azlanzadeh J; Christianson D; McGrath D; Spielman A
    N Engl J Med; 2000 Nov; 343(20):1454-8. PubMed ID: 11078770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of azithromycin in combination with quinine for the elimination of babesial infection in humans.
    Shih CM; Wang CC
    Am J Trop Med Hyg; 1998 Oct; 59(4):509-12. PubMed ID: 9790419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
    Wormser GP; Prasad A; Neuhaus E; Joshi S; Nowakowski J; Nelson J; Mittleman A; Aguero-Rosenfeld M; Topal J; Krause PJ
    Clin Infect Dis; 2010 Feb; 50(3):381-6. PubMed ID: 20047477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of babesiosis to a combined regimen of quinine and azithromycin.
    Shaio MF; Yang KD
    Trans R Soc Trop Med Hyg; 1997; 91(2):214-5. PubMed ID: 9196774
    [No Abstract]   [Full Text] [Related]  

  • 7. Fulminant babesiosis treated with clindamycin, quinine, and whole-blood exchange transfusion.
    Dorman SE; Cannon ME; Telford SR; Frank KM; Churchill WH
    Transfusion; 2000 Mar; 40(3):375-80. PubMed ID: 10738042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Babesiosis in humans: a treatment review.
    Weiss LM
    Expert Opin Pharmacother; 2002 Aug; 3(8):1109-15. PubMed ID: 12150690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Babesia microti infection in the hamster: failure of quinine and pyrimethamine in chemotherapeutic trials.
    Marcus LC; Mabray CJ; Sturgis GH
    Am J Trop Med Hyg; 1984 Jan; 33(1):21-3. PubMed ID: 6696180
    [No Abstract]   [Full Text] [Related]  

  • 10. Human Babesiosis.
    Waked R; Krause PJ
    Infect Dis Clin North Am; 2022 Sep; 36(3):655-670. PubMed ID: 36116841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinine in the treatment of Babesia divergens infections in humans.
    Brasseur P; Lecoublet S; Kapel N; Favennec L; Ballet JJ
    Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):840-1. PubMed ID: 8950568
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfusion-transmitted babesiosis in an immunocompromised patient: a case report and review.
    Wudhikarn K; Perry EH; Kemperman M; Jensen KA; Kline SE
    Am J Med; 2011 Sep; 124(9):800-5. PubMed ID: 21683324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
    Checa R; Montoya A; Ortega N; González-Fraga JL; Bartolomé A; Gálvez R; Marino V; Miró G
    Parasit Vectors; 2017 Mar; 10(1):145. PubMed ID: 28292316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of experimental babesiosis.
    Rowin KS; Tanowitz HB; Wittner M
    Ann Intern Med; 1982 Oct; 97(4):556-8. PubMed ID: 7125412
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of babesiosis.
    Ranque S
    N Engl J Med; 2001 Mar; 344(10):773-4. PubMed ID: 11236790
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model.
    Marley SE; Eberhard ML; Steurer FJ; Ellis WL; McGreevy PB; Ruebush TK
    Antimicrob Agents Chemother; 1997 Jan; 41(1):91-4. PubMed ID: 8980761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent parasitemia after acute babesiosis.
    Krause PJ; Spielman A; Telford SR; Sikand VK; McKay K; Christianson D; Pollack RJ; Brassard P; Magera J; Ryan R; Persing DH
    N Engl J Med; 1998 Jul; 339(3):160-5. PubMed ID: 9664092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clindamycin and quinine treatment for Babesia microti infections.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1983 Feb; 32(5):65-6, 72. PubMed ID: 6405180
    [No Abstract]   [Full Text] [Related]  

  • 19. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin.
    Falagas ME; Klempner MS
    Clin Infect Dis; 1996 May; 22(5):809-12. PubMed ID: 8722936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.
    Noedl H; Krudsood S; Chalermratana K; Silachamroon U; Leowattana W; Tangpukdee N; Looareesuwan S; Miller RS; Fukuda M; Jongsakul K; Sriwichai S; Rowan J; Bhattacharyya H; Ohrt C; Knirsch C
    Clin Infect Dis; 2006 Nov; 43(10):1264-71. PubMed ID: 17051490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.